Get the Stockscreener App
79.78
0.27%
-0.22
After Hours:
79.40
-0.38
-0.48%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $79.78, with a volume of 2.87M.
It is down -0.27% in the last 24 hours and up +11.58% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$80.00
Open:
$80.29
24h Volume:
2.87M
Relative Volume:
1.03
Market Cap:
$36.26B
Revenue:
$5.56B
Net Income/Loss:
$247.25M
P/E Ratio:
150.78
EPS:
0.5291
Net Cash Flow:
$1.24B
1W Performance:
+3.29%
1M Performance:
+11.58%
6M Performance:
+22.80%
1Y Performance:
+24.44%
1-Day Range:
$79.74
$80.50
1-Week Range:
$77.44
$80.50
52-Week Range:
$56.68
$80.50
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
79.78 | 37.58B | 5.56B | 247.25M | 1.24B | 0.5291 |
|
WELL
Welltower Inc
|
197.58 | 135.14B | 9.90B | 967.82M | 1.88B | 1.3269 |
|
DOC
Healthpeak Properties Inc
|
17.40 | 12.24B | 2.80B | 279.29M | 1.20B | 0.40 |
|
AHR
American Healthcare Reit Inc
|
49.23 | 8.76B | 2.07B | -37.81M | 84.15M | -0.27 |
|
CTRE
Caretrust Reit Inc
|
36.21 | 8.16B | 219.54M | 99.24M | 205.68M | 0.72 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Bulgarelli of Ventas sells $400k in stock - Investing.com
Ventas Insider Sold Shares Worth $400,205, According to a Recent SEC Filing - MarketScreener
Liquidity Mapping Around (VTR) Price Events - news.stocktradersdaily.com
Why Ventas Inc. stock stays on top picksQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com
Will Ventas Inc. (VEN) stock sustain uptrend momentumPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Why Ventas Inc. stock is favored by pension fundsJuly 2025 Recap & Advanced Technical Signal Analysis - newser.com
How Ventas Inc. stock reacts to Fed tightening2025 Market Outlook & Verified Swing Trading Watchlist - newser.com
How Ventas Inc. (VEN) stock benefits from digital adoptionJuly 2025 Short Interest & AI Driven Stock Reports - newser.com
Analyzing recovery setups for Ventas Inc. investorsJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Will Ventas Inc. stock reach Wall Street targetsDividend Hike & Weekly High Return Stock Forecasts - newser.com
Ventas Inc(VTR.US) Officer Sells US$3.26 Million in Common Stock - 富途牛牛
Will Ventas Inc. (VEN) stock profit from fiscal stimulusJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Can Ventas Inc. (VEN) stock double in coming years2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Can Ventas Inc. (VEN) stock sustain double digit ROE - newser.com
Why Ventas Inc. (VEN) stock stays on top picksQuarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
How buyback programs support Ventas Inc. (VEN) stockMarket Activity Recap & Daily Technical Forecast Reports - newser.com
Will Ventas Inc. (VEN) stock benefit from infrastructure bill2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Will Ventas Inc. stock outperform Nasdaq indexJuly 2025 Technicals & Low Risk Entry Point Guides - newser.com
Is Ventas Inc. stock in buy zone after pullbackIPO Watch & Weekly Top Stock Performers List - newser.com
Can Ventas Inc. (VEN) stock retain market dominance2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Forecasting Ventas Inc. price range with options dataJuly 2025 Final Week & Safe Entry Trade Signal Reports - newser.com
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):